{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:55:16Z","timestamp":1790056516011,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00595-019-01792-y","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T07:48:14Z","timestamp":1551944894000},"page":"785-794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Intraperitoneal chemotherapy for peritoneal metastases using sustained release formula of cisplatin-incorporated gelatin hydrogel granules"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0129-6275","authenticated-orcid":false,"given":"Kota","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutaro","family":"Gunji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"key":"1792_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11912-018-0703-0","volume":"20","author":"PH Sugarbaker","year":"2018","unstructured":"Sugarbaker PH. Peritoneal metastases from gastrointestinal cancer. Curr Oncol Rep 2018;20:62","journal-title":"Curr Oncol Rep"},{"key":"1792_CR2","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ejso.2015.08.172","volume":"41","author":"YR Huo","year":"2015","unstructured":"Huo YR, Richards A, Liauw W Morris DL. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: a systematic review and meta-analysis. Eur J Surg Oncol 2015;41:1578\u20131589.","journal-title":"Eur J Surg Oncol"},{"key":"1792_CR3","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1200\/JCO.2006.07.1142","volume":"24","author":"TD Yan","year":"2006","unstructured":"Yan TD, Black D, Savady R. Sugarbaker PH Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006;24:4011\u20134019.","journal-title":"J Clin Oncol"},{"key":"1792_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.21037\/jgo.2016.03.07","volume":"7","author":"J Esquivel","year":"2016","unstructured":"Esquivel J. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: Survival outcomes and patient selection. J Gastrointest Oncol 2016;7:72\u201378.","journal-title":"J Gastrointest Oncol"},{"key":"1792_CR5","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","volume":"22","author":"JH Helm","year":"2015","unstructured":"Helm JH, Miura JT, Glenn JA, Marcus RK, Larrieux G, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol 2015;22:1686\u20131693.","journal-title":"Ann Surg Oncol"},{"key":"1792_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ejca.2013.09.024","volume":"50","author":"D Elias","year":"2014","unstructured":"Elias D, Go\u00e9r\u00e9 D, Dumont F, Honor\u00e9 C, Dartigues P, et al. Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases. Eur J Cancer 2014;50:332\u2013340.","journal-title":"Eur J Cancer"},{"key":"1792_CR7","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1245\/s10434-018-6337-5","volume":"25","author":"HR Alexander","year":"2018","unstructured":"Alexander HR, Li CY, Kennedy TJ. Current management and future opportunities for peritoneal metastases: peritoneal mesothelioma. Ann Surg Oncol 2018;25:2159\u20132164.","journal-title":"Ann Surg Oncol"},{"key":"1792_CR8","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1245\/s10434-018-6488-4","volume":"25","author":"HA Choudry","year":"2018","unstructured":"Choudry HA, Pai RK. Management of mucinous appendiceal tumors. Ann Surg Oncol 2018;25:2135\u20132144.","journal-title":"Ann Surg Oncol"},{"key":"1792_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","volume":"36","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Quenet F, Bereder JM, Sid\u00e9ris L, et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2010;36:456\u2013462.","journal-title":"Eur J Surg Oncol"},{"key":"1792_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.critrevonc.2016.01.017","volume":"100","author":"D Baratti","year":"2016","unstructured":"Baratti D, Kusamura S, Pietrantonio F, Guaglio M, Niger M, et al. Progress in treatments for colorectal cancer peritoneal metastases during the years 2010\u20132015. A systematic review. Crit Rev Oncol Hematol 2016;100:209\u2013222.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1792_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ctrv.2016.06.007","volume":"48","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker PH. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care. Cancer Treat Rev 2016;48:42\u201349.","journal-title":"Cancer Treat Rev"},{"key":"1792_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1023\/A:1008215213739","volume":"9","author":"J Lokich","year":"1998","unstructured":"Lokich J, Anderson N. Carboplatin versus cisplatin in solid tumors: an analysis of the literature. Ann Oncol 1998;9:13\u201321.","journal-title":"Ann Oncol"},{"key":"1792_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","volume":"9","author":"W Koizumi","year":"2008","unstructured":"Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215\u201321.","journal-title":"Lancet Oncol"},{"key":"1792_CR14","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1200\/JCO.1994.12.5.970","volume":"12","author":"T Sautner","year":"1994","unstructured":"Sautner T, Hofbauer F, Depisch D, Schiessel R, Jakesz R. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol 1994;12:970\u2013974.","journal-title":"J Clin Oncol"},{"key":"1792_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s10120-011-0027-3","volume":"14","author":"I Miyashiro","year":"2011","unstructured":"Miyashiro I, Furukawa H, Sasako M, Yamamoto S, Nashimoto A, et al. Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2. Gastric Cancer 2011;14:212\u2013218.","journal-title":"Gastric Cancer"},{"key":"1792_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751\u201360.","journal-title":"Nat Nanotechnol"},{"key":"1792_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0168-3659(95)00165-4","volume":"39","author":"M Yokoyama","year":"1996","unstructured":"Yokoyama M, Okano T, Sakurai Y, Suwa S, Kataoka K. Introduction of cisplatin into polymeric micelle. J Controll Release 1996;39:351\u2013356.","journal-title":"J Controll Release"},{"key":"1792_CR18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/sj.bjc.6602772","volume":"93","author":"H Uchino","year":"2005","unstructured":"Uchino H, Matsumura Y, Negishi T, Koizumi F, Hayashi T, et al. Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats. Br J Cancer 2005;93:678\u2013687.","journal-title":"Br J Cancer"},{"key":"1792_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ijc.10242","volume":"99","author":"H Iinuma","year":"2002","unstructured":"Iinuma H, Maruyama K, Okinaga K, Sasaki K, Sekine T, et al. Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer. Int J Cancer 2002;99:130\u2013137.","journal-title":"Int J Cancer"},{"key":"1792_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.surg.2013.04.054","volume":"154","author":"S Gunji","year":"2013","unstructured":"Gunji S, Obama K, Matsui M, Tabata Y, Sakai Y. A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin. Surgery 2013;154:991\u2013999.","journal-title":"Surgery"},{"key":"1792_CR21","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.actbio.2012.01.016","volume":"8","author":"M Matsui","year":"2012","unstructured":"Matsui M, Tabata Y. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels. Acta Biomater 2012;8:1792\u20131801.","journal-title":"Acta Biomater"},{"key":"1792_CR22","first-page":"657","volume":"28","author":"T Ahmed","year":"2015","unstructured":"Ahmed T, Review. Approaches to develop PLGA based in situ gelling system with low initial burst. Pak J Pharm Sci 2015;28:657\u2013665.","journal-title":"Pak J Pharm Sci"},{"key":"1792_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02980037","volume":"27","author":"Y Yeo","year":"2004","unstructured":"Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharmacal Res 2004;27:1\u201312.","journal-title":"Arch Pharmacal Res"},{"key":"1792_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejpb.2016.05.006","volume":"104","author":"MH Nguyen","year":"2016","unstructured":"Nguyen MH, Tran TT, Hadinoto K. Controlling the burst release of amorphous drug-polysaccharide nanoparticle complex via crosslinking of the polysaccharide chains. Eur J Pharm Biopharm 2016;104:156\u2013163.","journal-title":"Eur J Pharm Biopharm"},{"key":"1792_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jconrel.2005.09.023","volume":"109","author":"S Young","year":"2005","unstructured":"Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005;109:256\u2013274.","journal-title":"J Control Release"},{"key":"1792_CR26","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/S0142-9612(99)00121-0","volume":"20","author":"Y Tabata","year":"1999","unstructured":"Tabata Y, Ikada Y. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials. 1999;20:2169\u201375.","journal-title":"Biomaterials"},{"key":"1792_CR27","doi-asserted-by":"publisher","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","volume":"27","author":"EC Smyth","year":"2016","unstructured":"Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, et al. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27:v38","journal-title":"Ann Oncol"},{"key":"1792_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1040-8428(99)00017-7","volume":"31","author":"M Markman","year":"1999","unstructured":"Markman M, Intraperitoneal chemotherapy. Crit Rev Oncol Hematol. 1999;31:239\u201346.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1792_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1470-2045(03)01074-X","volume":"4","author":"M Markman","year":"2003","unstructured":"Markman M. Intraperitoneal antineoplastic drug delivery: rationale and results. Lancet Oncol 2003;4:277\u2013283.","journal-title":"Lancet Oncol"},{"key":"1792_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006;354:34\u201343.","journal-title":"N Engl J Med"},{"key":"1792_CR31","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1245\/s10434-009-0706-z","volume":"16","author":"H Okabe","year":"2009","unstructured":"Okabe H, Ueda S, Obama K, Hosogi H, Sakai Y. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol 2009;16:3227\u20133236.","journal-title":"Ann Surg Oncol"},{"key":"1792_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10120-006-0369-4","volume":"9","author":"S Satoh","year":"2006","unstructured":"Satoh S, Hasegawa S, Ozaki N, Okabe H, Watanabe G, et al. Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1\/CDDP combination. Gastric Cancer. 2006;9:129\u201335.","journal-title":"Gastric Cancer"},{"key":"1792_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10120-011-0066-9","volume":"15","author":"S Satoh","year":"2012","unstructured":"Satoh S, Okabe H, Teramukai S, Hasegawa S, Ozaki N, et al. Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer. Gastric Cancer 2012;15:61\u201369.","journal-title":"Gastric Cancer"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-019-01792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-019-01792-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-019-01792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:20:02Z","timestamp":1583454002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-019-01792-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1792"],"URL":"https:\/\/doi.org\/10.1007\/s00595-019-01792-y","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,7]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors confirm that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}